Genic Co Ltd
KOSDAQ:123330
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
17 070
42 600
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Genic Co Ltd stock under the Base Case scenario is 78 051.83 KRW. Compared to the current market price of 19 660 KRW, Genic Co Ltd is Undervalued by 75%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Genic Co Ltd.
| FR |
|
L'Oreal SA
PAR:OR
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
|
| JP |
|
Kao Corp
TSE:4452
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Genic Co Ltd
Balance Sheet Decomposition
Genic Co Ltd
| Current Assets | 34B |
| Cash & Short-Term Investments | 7.6B |
| Receivables | 17.3B |
| Other Current Assets | 9.1B |
| Non-Current Assets | 16.1B |
| Long-Term Investments | 445.5m |
| PP&E | 15B |
| Intangibles | 11.4m |
| Other Non-Current Assets | 677.8m |
| Current Liabilities | 19.7B |
| Accounts Payable | 8.1B |
| Accrued Liabilities | 2.1B |
| Short-Term Debt | 5B |
| Other Current Liabilities | 4.5B |
| Non-Current Liabilities | 777.9m |
| Long-Term Debt | 706.3m |
| Other Non-Current Liabilities | 71.6m |
Free Cash Flow Analysis
Genic Co Ltd
| KRW | |
| Free Cash Flow | KRW |
Earnings Waterfall
Genic Co Ltd
|
Revenue
|
77B
KRW
|
|
Cost of Revenue
|
-55.4B
KRW
|
|
Gross Profit
|
21.6B
KRW
|
|
Operating Expenses
|
-6.7B
KRW
|
|
Operating Income
|
14.9B
KRW
|
|
Other Expenses
|
-17.4m
KRW
|
|
Net Income
|
14.9B
KRW
|
Profitability Score
Profitability Due Diligence
Genic Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Genic Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Genic Co Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Score
Genic Co Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Genic Co Ltd
According to Wall Street analysts, the average 1-year price target for Genic Co Ltd is 42 840 KRW with a low forecast of 42 420 KRW and a high forecast of 44 100 KRW.
Dividends
Current shareholder yield for Genic Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Genic Co Ltd stock under the Base Case scenario is 78 051.83 KRW.
Compared to the current market price of 19 660 KRW, Genic Co Ltd is Undervalued by 75%.